1. Home
  2. Live Updates
  3. Thrombus

Live Breaking News & Updates on Thrombus

Stay informed with the latest breaking news from Thrombus on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Thrombus and stay connected to the pulse of your community

FDA OKs Danicopan for Extravascular Hemolysis in PNH

A tablet has been approved for a common complication during treatment for a rare blood disorder.

Astrazeneca , Drug-administration , Risk-evaluation , Mitigation-strategy , Patient-safety , Hemolysis , Blood , Blood-transfusion , Thromboembolism , Thrombus , Lood-clot

Las Palmas Medical Center leads El Paso with innovative blood clot removal technique

Las Palmas Medical Center recently became the first hospital in El Paso to remove a blood clot through a new, innovative technique.

Texas , United-states , El-paso , Las-palmas-medical-center , Waseem-shami , Las-palmas-medical , Health-medical-pharma , Thrombus , Thrombectomy , Embolectomy , Hematology , Vein

Catheter-Directed Plan Improves Pulmonary Artery Occlusion

The Bashir endovascular catheter was designed to maximize thrombus reduction via a pharmacomechanical infusion.

United-states , Philadelphia , Pennsylvania , Commonwealth-of-pennsylvania , Temple-university , Temple-university-hospital , Riyaz-bashir , Thrombolex-inc , Blood-institute , National-heart , Endovascular-administration , Thrombus-burden

Impressive Bleeding Profile With Factor XI Inhibitor in AF

Further details from the phase 2b AZALEA trial of the factor XI inhibitor abelacimab show significant reductions in major and clinically relevant nonmajor bleeding vs rivaroxaban for patients with AF.

Boston , Massachusetts , United-states , North-carolina , Philadelphia , Pennsylvania , Duke-university , American , John-alexander , Manesh-patel , American-heart-association , Christian-ruff

No More Hot Flashes? AI Device Could Stop Menopause Symptom

New wearable tech can predict menopausal vasomotor symptoms and initiate cooling in less than a second, potentially stopping the hot flash before it starts.

Matthew-smith , Karen-adams , Michael-busa , Healthy-aging-program , Human-health , Stanford-university , Menopause-society , Healthy-aging-program-at-stanford-university , Massachusetts-institute-of-technology , University-of-massachusetts-amherst , Massachusetts-amherst

Study Finds Ruxolitinib Effective, Safe for Children With AD

There were no significant safety signals in the younger pediatric population, and 'no treatment-emergent adverse events suggestive of systemic JAK inhibition,' Dr Lawrence Eichenfield said.

San-diego , California , United-states , Norway , Berlin , Germany , Lawrencef-eichenfield , Thrasyvoulos-tzellos , European-academy-of-dermatology , University-of-california , Nordland-hospital , European-academy

CV, VTE Risk Not Seen in Derm Studies of JAK Inhibitors

'There remains a knowledge gap regarding the risk of JAK inhibitor use and VTE and/or MACE in the dermatologic population,' the study authors wrote.

Chicago , Illinois , United-states , Northwestern-university , Raj-chovatiya , Michaels-garshick , Bristol-myers-squibb , Pfizer , York-university-langone-health , Kiniksa-pharmaceuticals , New-york-university-langone-health , Preferred-reporting-items

FDA Greenlights Balfaxar for Warfarin Reversal

Balfaxar helps restore blood coagulation by replenishing the levels of clotting factors.

United-states , International-normalized-ratio , International-units , Drug-administration , Patient-safety , Thromboembolism , Stroke-cerebrovascular-accident-cva , Surgery , Coagulation , Blood , Thrombus

Factor XI Inhibitors: Promise of a Safe Anticoagulant?

The quest for an anticoagulant that can prevent cardiovascular events without bleeding is something of a holy grail in cardiovascular medicine. Could factor XI inhibitors be the long-sought answer?

North-carolina , United-states , Massachusetts , Duke-university-medical-center , Boston , John-alexander , Manesh-patel , Candidates-in-development , American-heart-association-scientific-sessions , Christian-ruff , Atrial-fibrillation , F-atrial-fibrillation-

Strategy to Prevent Blood Clots, Deaths in Lung/GI Cancer

An approach that involves stratifying patients by thrombosis risk reduced the incidence of thromboembolism and death among high-risk individuals with lung and GI cancers.

Melbourne , Victoria , Australia , Marliese-alexander , Peter-maccallum-cancer-centre , Cleveland-clinic-taussig-cancer-institute , Alok-khorana , Cleveland-clinic-taussig-cancer , Thromboembolism , Cancer , Alignant-neoplasia , Arcinoma